Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 1 | -$0.92 | -$0.92 | -$0.92 |
Q2 2025 | 1 | -$0.53 | -$0.53 | -$0.53 |
Q3 2025 | 1 | -$0.52 | -$0.52 | -$0.52 |
Q4 2025 | 1 | -$0.52 | -$0.52 | -$0.52 |
Helius Medical Technologies, Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.99 earnings per share for the quarter, topping analysts' consensus estimates of $-1.06 by $0.07. The company had revenue of 51,000 for the quarter and had revenue of 644,000 for the year. Helius Medical Technologies, Inc. has generated $-15 earnings per share over the last year ($-14.56 diluted earnings per share) and currently has a price-to-earnings ratio of -0.17. Helius Medical Technologies, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/12/2024 | Q3 2024 | -$1.06 | -$0.99 | 0.07 | $150,000 | $51,000 |
08/12/2024 | Q2 2024 | -$0.50 | -$0.64 | -0.14 | $150,000 | $182,000 |
05/13/2024 | Q1 2024 | -$3.87 | -$3.08 | 0.79 | N/A | $135,000 |
03/28/2024 | Q4 2023 | -$4.05 | -$1.47 | 2.58 | N/A | $134,000 |
11/09/2023 | Q3 2023 | -$6.00 | -$5.49 | 0.51 | $345,000 | $143,000 |
08/10/2023 | Q2 2023 | -$5.50 | -$2.92 | 2.58 | $188,333 | $256,000 |
05/11/2023 | Q1 2023 | -$5.00 | -$1.91 | 3.09 | N/A | $111,000 |
03/09/2023 | Q4 2022 | -$5.50 | -$12.76 | -7.26 | N/A | $282,000 |
11/14/2022 | Q3 2022 | -$12.00 | $8.32 | 20.32 | $167,500 | $196,000 |
08/15/2022 | Q2 2022 | -$1.12 | -$48.49 | -47.37 | $360,000 | $119,000 |
05/12/2022 | Q1 2022 | -$1.13 | -$51.75 | -50.62 | N/A | $190,000 |
03/14/2022 | Q4 2021 | -$1.16 | -$65.60 | -64.44 | N/A | $258,000 |
11/09/2021 | Q3 2021 | N/A | -$100.72 | N/A | $84,500 | $109,000 |
08/12/2021 | Q2 2021 | -$76.50 | -$129.05 | -52.55 | $95,000 | $71,000 |
05/17/2021 | Q1 2021 | -$61.00 | -$82.50 | -21.5 | N/A | $84,000 |
03/10/2021 | Q4 2020 | N/A | -$88.57 | N/A | N/A | $191,000 |
11/12/2020 | Q3 2020 | -$3.15 | -$135.00 | -131.85 | $100,000 | $131,000 |
08/12/2020 | Q2 2020 | -$4.06 | -$145.00 | -140.94 | $100,000 | $133,000 |
05/11/2020 | Q1 2020 | N/A | -$269.00 | N/A | N/A | $207,000 |
03/12/2020 | Q4 2019 | -$7.21 | -$339.01 | -331.8 | N/A | $152,000 |
Helius Medical Technologies, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based offlast year's report dates.
In the previous quarter, Helius Medical Technologies, Inc. (:HSDT) reported $-0.99 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.06 by $0.07.
The conference call for Helius Medical Technologies, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Helius Medical Technologies, Inc.'s latest earnings report can be read online.
Helius Medical Technologies, Inc. (:HSDT) has a recorded annual revenue of $644,000.
Helius Medical Technologies, Inc. (:HSDT) has a recorded net income of $-8,850,000.Helius Medical Technologies, Inc. has generated $-14.56 earnings per share over the last four quarters.
Helius Medical Technologies, Inc. (:HSDT) has a price-to-earnings ratio of -0.17 and price/earnings-to-growth ratio is -0.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED